SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950133-03-002117
Filing Date
2003-06-10
Accepted
2003-06-10 17:16:57
Documents
1
Group Members
BIOTECH TARGET N.V.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/AMENDMENT NO. 4 w87379asc13gza.htm SC 13G/A 44739
  Complete submission text file 0000950133-03-002117.txt   46803
Mailing Address 3172 PORTER DRIVE PALO ALTO CA 94304
Business Address 3172 PORTER DR PALO ALTO CA 94304 6503848500
CV THERAPEUTICS INC (Subject) CIK: 0000921506 (see all company filings)

IRS No.: 431570294 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-47551 | Film No.: 03739512
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address VODERGASSE 3 SWITZERLAND SCHAFFHAUSEN V8 CH-8300
Business Address VODERGASSE 3 SWITZERLAND SCHAFFHAUSEN V8 CH-8300 411724 59 59
BB BIOTECH AG (Filed by) CIK: 0000924223 (see all company filings)

State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 0000